Wedbush Securities’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-15,498
| Closed | -$37K | – | 1233 |
|
2024
Q1 | $37K | Hold |
15,498
| – | – | ﹤0.01% | 1216 |
|
2023
Q4 | $26K | Hold |
15,498
| – | – | ﹤0.01% | 1074 |
|
2023
Q3 | $30K | Hold |
15,498
| – | – | ﹤0.01% | 1040 |
|
2023
Q2 | $22K | Hold |
15,498
| – | – | ﹤0.01% | 1052 |
|
2023
Q1 | $33K | Sell |
15,498
-9,000
| -37% | -$19.2K | ﹤0.01% | 1052 |
|
2022
Q4 | $28K | Sell |
24,498
-500
| -2% | -$571 | ﹤0.01% | 1029 |
|
2022
Q3 | $41K | Sell |
24,998
-3,000
| -11% | -$4.92K | ﹤0.01% | 1012 |
|
2022
Q2 | $37K | Hold |
27,998
| – | – | ﹤0.01% | 1044 |
|
2022
Q1 | $45K | Sell |
27,998
-2,000
| -7% | -$3.22K | ﹤0.01% | 1078 |
|
2021
Q4 | $62K | Sell |
29,998
-1,000
| -3% | -$2.07K | ﹤0.01% | 1150 |
|
2021
Q3 | $120K | Buy |
30,998
+13,000
| +72% | +$50.3K | 0.01% | 1117 |
|
2021
Q2 | $58K | Hold |
17,998
| – | – | ﹤0.01% | 1144 |
|
2021
Q1 | $39K | Sell |
17,998
-2,500
| -12% | -$5.42K | ﹤0.01% | 1066 |
|
2020
Q4 | $46K | Buy |
20,498
+3,000
| +17% | +$6.73K | ﹤0.01% | 857 |
|
2020
Q3 | $47K | Sell |
17,498
-3,000
| -15% | -$8.06K | ﹤0.01% | 887 |
|
2020
Q2 | $63K | Hold |
20,498
| – | – | 0.01% | 892 |
|
2020
Q1 | $40K | Sell |
20,498
-1,000
| -5% | -$1.95K | ﹤0.01% | 835 |
|
2019
Q4 | $61K | Hold |
21,498
| – | – | 0.01% | 956 |
|
2019
Q3 | $79K | Sell |
21,498
-3,000
| -12% | -$11K | 0.01% | 914 |
|
2019
Q2 | $102K | Buy |
24,498
+6,500
| +36% | +$27.1K | 0.01% | 902 |
|
2019
Q1 | $92K | Hold |
17,998
| – | – | 0.01% | 861 |
|
2018
Q4 | $62K | Hold |
17,998
| – | – | 0.01% | 784 |
|
2018
Q3 | $108K | Hold |
17,998
| – | – | 0.01% | 837 |
|
2018
Q2 | $114K | Sell |
17,998
-18,000
| -50% | -$114K | 0.01% | 800 |
|
2018
Q1 | $171K | Buy |
35,998
+5,499
| +18% | +$26.1K | 0.02% | 706 |
|
2017
Q4 | $102K | Buy |
+30,499
| New | +$102K | 0.01% | 786 |
|